Ashland Inc. ASH
New risk paragraphs, branching off last year
Each branch is a paragraph in Risk Factors with nothing like it in the 10-K filed Nov 18, 2024. A box jumps to the paragraph as filed, below.
Paragraphs with nothing like them in last year's 10-K
4 paragraphs in Risk Factors of the 10-K filed Nov 20, 2025 with nothing like them in the 10-K filed Nov 18, 2024. Quoted exactly. Paragraphs that were only edited are under 10-K change.
sales, increased expenses, impairment of goodwill or other intangible assets, and other adverse effects on the Company’s financial condition and results of operations.
Ashland’s global business operations present a range of challenges, particularly related to tariffs, trade policy, and geopolitical risks. The imposition of new tariffs or trade quotas, or the impairment of existing trade agreements, risks that have become more pronounced amid ongoing global trade tensions and protectionist measures, could significantly impair Ashland’s
financial performance. The uncertainty and volatility created by these policies, including heightened trade disputes, renegotiations of major agreements, and the risk of additional withholding taxes or restrictions on foreign trade and investment (such as currency exchange controls), may disrupt supply chains, increase costs, limit market access for Ashland’s products, and adversely affect profitability in U.S. dollars for products and services provided abroad. Ongoing trade disputes between the United States and Europe, Latin America, and the Asia-Pacific region could further negatively impact Ashland if they worsen.
The nature of our businesses, the markets we serve, and the extensive geographic profile of our operations make Ashland a target of cybersecurity threats. Cybersecurity threats in general are increasing and becoming more advanced and could occur as a result of the activity of hackers, employee error or employee misconduct. In addition, bad actors are becoming more
Paragraphs in the 10-Q filed Jul 29, 2026 that were not in the one before
New in the latest 10-Q
38 paragraphs in the 10-Q filed Jul 29, 2026 with nothing like them in the 10-Q filed Apr 29, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.
Financial statements and notes
of $2 million within the investing activities section of the Statement of Condensed Consolidated Cash Flows for the nine months ended June 30, 2026.
Read in the 10-Q
Due to the ongoing assessment of certain matters associated with previous divestitures, subsequent adjustments to these divestitures may continue in future periods in the loss from discontinued operations, net of income taxes caption in the Statements of Condensed Consolidated Comprehensive Income (Loss).
Read in the 10-Q
The following divested businesses represent disposal groups that qualified as discontinued operations in previous periods and impacted discontinued operations for the three and nine months ended June 30, 2026 and 2025:
Read in the 10-Q
The sale of Ashland Water Technologies ("Water Technologies") business divested in 2014;
Read in the 10-Q
cost gain loss June 30, 2026 Demand deposit $ 2 $ - $ - $ 2 Equity mutual fund 86 76 - 162 Fixed income mutual fund 201 - (33) 168 Fair value $ 289 $ 76 $ (33) $ 332 September 30, 2025 Demand deposit $ 3 $ - $ - $ 3 Equity mutual fund 103 67 - 170 Fixed income mutual fund 205 - (31) 174 Fair value $ 311 $ 67 $ (31) $ 347 The following table presents the investment income, net gains realized, funds restricted for specific transactions, and disbursements related to restricted investments:
Read in the 10-Q
Show the other 33
NOTE G - GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill Ashland tests goodwill and other indefinite-lived intangible assets for impairment annually as of July 1 or whenever events and circumstances indicate an impairment may have occurred.
Read in the 10-Q
No indicators of impairment were identified during the three and nine months ended June 30, 2026.
Read in the 10-Q
During the three months ended June 30, 2025, Ashland performed an interim quantitative goodwill impairment assessment following a sustained decline in the market price of its Common Stock and weakened operating performance resulting from a challenging macroeconomic environment. The assessment indicated that the carrying values of the Life Sciences and Specialty Additives reporting units exceeded their estimated fair values.
Read in the 10-Q
Prior to the impairment, goodwill balances associated with the Life Sciences and Specialty Additives reporting units were $841 million and $443 million, respectively. The goodwill impairment charges were not deductible for income tax purposes.
Read in the 10-Q
The fair value estimates used in the interim quantitative impairment assessment were based on an income approach utilizing Level 3 inputs, including significant assumptions regarding future cash flows, sales growth rates, operating income (loss) before income taxes, depreciation and amortization ("EBITDA") growth rates, terminal growth rates, and discount rates.
Read in the 10-Q
The following is a progression of goodwill by reportable segment for the nine months ended June 30, 2026:
Read in the 10-Q
As of both June 30, 2026 and September 30, 2025, there were accumulated impairments of $ 375 million, $ 356 million, $ 505 million and $ 90 million related to the Life Sciences, Personal Care, Specialty Additives and Intermediates reportable segments, respectively.
Read in the 10-Q
Other intangible assets principally consist of trademarks and trade names, intellectual property and customer lists. Intangible assets classified as finite are amortized on a straight-line basis over their estimated useful lives. The cost of trademarks and trade names is amortized principally over 3 to 20 years, intellectual property over 3 to 20 years, and customer lists over 10 to 24 years.
Read in the 10-Q
Ashland annually reviews, as of July 1, indefinite-lived intangible assets for impairment or whenever events or changes in circumstances indicate that carrying amounts may not be recoverable.
Read in the 10-Q
No indicators of impairment were identified for indefinite-lived trademarks and trade names during the three and nine months ended June 30, 2026.
Read in the 10-Q
NOTE H - DEBT AND OTHER FINANCING ACTIVITIES The following table summarizes Ashland’s long-term debt as of: (In millions) June 30, 2026 September 30, 2025 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── 3.375% Senior Notes, due 2031 $ 450 $ 450 2.00% Senior Notes, due 2028 (Euro 500 million principal) 571 586 6.875% Notes, due 2043 282 282 6.50% Junior Subordinated Notes, due 2029 76 72 Other(a) (5) (6) Long-term debt (less debt issuance costs)(b) $ 1,374 $ 1,384 (a) Other includes $ 9 million and $ 10 million of debt issuance costs as of June 30, 2026 and September 30, 2025, respectively. (b) The current portion of the long-term debt was zero for both June 30, 2026 and September 30, 2025. The scheduled aggregate maturities for long-term debt by year (excluding debt issuance costs) are as follows as of June 30, 2026: zero 2026, $4 million in 2027, $571 million in 2028, $97 million in 2029, zero in 2030 and $450 million in 2031. Credit agreements and refinancing On May 28, 2026 (the “Closing Date”), Ashland Inc. and its Swiss subsidiary, Ashland Industries Europe GmbH ("the Swiss Borrower"), entered into a Second Amended and Restated Credit Agreement (the “2026 Credit Agreement”). The 2026 Credit Agreement provides for a $500 million five-year revolving credit facility (including a $125 million letter of credit sublimit) ("The Revolving Facility"), which may be drawn by Ashland or the Swiss Borrower. The 2026 Credit Agreement amends and restates the Amended and Restated Credit Agreement dated as of July 22, 2022.
Read in the 10-Q
The obligations of the Swiss Borrower under the 2026 Revolving Facility are guaranteed by Ashland. The Revolving Facility is unsecured.
Read in the 10-Q
At Ashland’s option, loans issued under the 2026 Credit Agreement will bear interest at (a) in the case of loans denominated in U.S. dollars, either Term Secured Overnight Financing Rate ("SOFR") or an alternate base rate and (b) in the case of loans denominated in Euros, Euro Interbank Offered Rate ("EURIBOR"), in each case plus the applicable interest rate margin. Loans will initially bear interest at Term SOFR or EURIBOR plus 1.375% per annum, in the case of Term SOFR borrowings or EURIBOR borrowings, respectively, or at the alternate base rate plus 0.375%, in the case of alternate base rate borrowings, through and including the date of delivery of a quarterly compliance certificate and thereafter the interest rate will fluctuate between Term SOFR or EURIBOR plus 1.250% per annum and Term SOFR or EURIBOR plus 1.750% per annum (or between the alternate base rate plus 0.250% per annum and the alternate base rate plus 0.750% annum), based upon the Consolidated Net Leverage Ratio (as defined in the 2026 Credit Agreement) at such time. In addition, Ashland will initially be required to pay fees of 0.175% per annum on the daily unused amount of the Revolving Facility through and including the date of delivery of a compliance certificate, and thereafter the fee rate will fluctuate between 0.125% and 0.275% per annum, based upon the Consolidated Net Leverage Ratio.
Read in the 10-Q
The 2026 Credit Agreement contains usual and customary representations and warranties, and usual and customary affirmative and negative covenants, including limitations on liens, additional subsidiary indebtedness, investments, mergers, dispositions, restricted payments, changes in the nature of business, affiliate transactions, restrictions on distributions by subsidiaries, use of proceeds, accounting changes and other customary limitations, as well as financial covenants (including maintenance of a maximum Consolidated Net Leverage Ratio and a minimum Consolidated Interest Coverage Ratio (as defined in the 2026 Credit Agreement)). The 2026 Credit Agreement also contains usual and customary events of default, including non-payment of principal, interest, fees and other amounts, material breach of a representation or warranty, non-performance of covenants and obligations, default on other material debt, bankruptcy or insolvency, material judgments, incurrence of certain material ERISA liabilities, impairment of loan documentation and change of control.
Read in the 10-Q
Ashland incurred and paid $2 million of debt issuance costs in connection with the 2026 Credit Agreement during the three and nine months ended June 30, 2026. These costs are being amortized over the term of the 2026 Credit Agreement using the straight-line method and are included within net interest and other (income) expense in the Statements of Consolidated Comprehensive Income (Loss). This amount was also recorded within debt issuance costs paid in the cash flows used by financing activities from continuing operations section of the Statement of Condensed Consolidated Cash Flows for the nine months ended June 30, 2026.
Read in the 10-Q
NOTE K - EMPLOYEE BENEFIT PLANS Restructuring and plan remeasurement In June 2026, Ashland completed a buy-out transaction for certain retirees participating in two of its U.S. defined benefit pension plans. Under the buy-out transaction, the pension plans purchased group annuity contracts from an insurance company, which assumed responsibility for future benefit payments to the
Read in the 10-Q
affected retirees. As a result, Ashland was relieved of the related pension obligations and derecognized the associated projected benefit obligations and related plan assets from its Condensed Consolidated Balance Sheet. The affected pension plans continue to operate following the transaction, with remaining active, deferred vested and retiree participants. The buy-in transaction triggered a remeasurement of the affected pension plans immediately prior to settlement. Based on the remeasurement and settlement accounting, Ashland recognized a settlement gain of $2 million within the other net periodic benefit (income) loss caption of the Statements of Condensed Consolidated Comprehensive Income (Loss) for the three and nine months ended June 30, 2026. As of June 30, 2026, Ashland transferred approximately $30 million of projected benefit obligations and $28 million of related plan assets associated with the affected retirees to the insurance company. The remaining projected benefit obligations and related plan assets of the two pension plans continue to be reflected in Ashland's Condensed Consolidated Balance Sheet.
Read in the 10-Q
For the nine months ended June 30, 2026, Ashland contributed $5 million to its U.S. pension plans and $5 million to its non-U.S. pension plans. Ashland expects to make additional contributions of $1 million to its U.S. pension plans and $1 million to its non-U.S. pension plans during the remainder of fiscal 2026.
Read in the 10-Q
• $8 million benefit related to domestic tax credits during the three months ended June 30, 2026; and
Read in the 10-Q
• $8 million benefit related to domestic tax credits during the nine months ended June 30, 2026; and
Read in the 10-Q
• Tax credit - During the three and nine months ended June 30, 2026, Ashland recorded a $8 million benefit related to domestic tax credits;
Read in the 10-Q
Personal Care Three months ended June 30 Nine months ended June 30 (In millions) 2026 2025 Change 2026 2025 Change Operating income $ 29 $ 25 $ 4 $ 67 $ 64 $ 3 Depreciation and amortization(a) 15 15 — 45 51 (6) EBITDA $ 44 $ 40 4 $ 112 $ 115 (3) Held for sale depreciation and amortization — — — 1 (2) 3 Other plant optimization costs 1 1 — 1 3 (2) Adjusted EBITDA $ 45 $ 41 $ 4 $ 114 $ 116 $ (2) Operating income as a percent of sales 18.7% 17.0% 170 bps 15.7% 15.0% 70 bps Adjusted EBITDA as a percent of sales 29.0% 27.9% 110 bps 26.6% 27.2% -60 bps
Read in the 10-Q
Specialty Additives is comprised of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. Solutions include coatings additives
Read in the 10-Q
Specialty Additives Three months ended June 30 Nine months ended June 30 (In millions) 2026 2025 Change 2026 2025 Change Operating income (loss) $ 3 $ (345) $ 348 $ (12) $ (343) $ 331 Depreciation and amortization(a) 15 17 (2) 44 48 (4) EBITDA 18 (328) 346 32 (295) 327 Goodwill impairment — 331 (331) — 331 (331) Accelerated depreciation — 19 (19) 3 19 (16) Environmental reserve adjustments — 2 (2) — 2 (2) Other plant optimization costs 2 2 — 16 7 9 Adjusted EBITDA $ 20 $ 26 $ (6) $ 51 $ 64 $ (13) Operating income (loss) as a percent of sales 2.2% -263.4% Not meaningful -3.2% -90.3% Not meaningful Adjusted EBITDA as a percent of sales 14.7% 19.8% -510 bps 13.7% 16.8% -310 bps
Read in the 10-Q
Other items in the current quarter included accelerated depreciation of $1 million and a tax credit of $8 million.
Read in the 10-Q
During May 2026, Ashland entered into a Second Amended and Restated Credit Agreement (the "2026 Credit Agreement"). The 2026 Credit Agreement provides for a $500 million five-year revolving credit facility (including a $125 million letter of credit sublimit) (the “Revolving Credit Facility”). Proceeds of borrowings under the 2026 Revolving Credit Facility are intended to provide ongoing working capital and for other general corporate purposes. See Note H of the Notes to Condensed Consolidated Financial Statements for more information.
Read in the 10-Q
Nine months ended June 30 (In millions) 2026 2025 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Cash provided (used) by: Operating activities from continuing operations $ 295 $ 94 Investing activities from continuing operations 22 — Financing activities from continuing operations (60) (161) Discontinued operations (31) (27) Effect of currency exchange rate changes on cash and cash equivalents(a) (1) 1 Net increase (decrease) in cash and cash equivalents $ 225 $ (93)
Read in the 10-Q
Ashland is reaffirming its full year fiscal 2026 sales guidance of $1,835 to $1,870 million and its Adjusted EBITDA guidance of $385 to $400 million. Ashland is also revising its adjusted EPS outlook to low-to-mid-single digit growth from mid-to-high-single digit growth, reflecting a higher tax rate associated with unfavorable discrete items. The outlook reflects continued growth across the portfolio, ongoing momentum in higher value applications, increasing realization of recent pricing actions and strong cash generation.
Read in the 10-Q
Despite a mixed macroeconomic backdrop, Ashland’s core Life Sciences and Personal Care end markets continue to demonstrate resilient demand, supported by stable fundamentals, continued innovation adoption from customers and strong commercial execution. Specialty Additives trends continue to improve, driven by share gains in coatings and performance specialties.
Read in the 10-Q
Ashland continues to benefit from growth in differentiated, higher value applications, including biofunctional actives, microbial protection, injectables and tablet coatings. Recent pricing actions are contributing to results and are expected to provide greater benefit in the fourth quarter as realization increases. Raw material and
Read in the 10-Q
freight costs are expected to remain elevated amid geopolitical supply pressures, although Ashland expects pricing actions to offset these impacts over time.
Read in the 10-Q
Other information
On February 26, 2026, Dr. Osama M. Musa, Ashland’s Senior Vice President and Chief Technology Officer, entered into a Rule 10b5-1 trading arrangement, to exercise up to an aggregate of 18,443 stock appreciation rights related to Ashland’s common stock and the corresponding sale of the resulting shares. The duration of the trading arrangement is until the earlier of (1) December 31, 2026, (2) the date on which all transactions under the trading arrangement are completed, or (3) at such time as the trading arrangement is otherwise terminated or expires according to its terms.
Read in the 10-Q
Item 6
10.1 Second Amended and Restated Credit Agreement dated as of May 28, 2026, among Ashland Inc., Ashland Industries Europe GmbH, each lender from time to time party thereto, The Bank of Nova Scotia, Houston Branch, as administrative agent, swing line lender and a letter of credit issuer, each other letter of credit issuer from time to time party thereto and Citibank, N.A., as syndication agent, filed as Exhibit 10.1 to Ashland’s Form 8-K filed on May 29, 2026 (SEC File No. 333-211719) and incor...
Read in the 10-Q
The 10-Q's risk factors against the 10-K
Item 1A of the 10-Q filed Jul 29, 2026 against Item 1A of the 10-K filed Nov 20, 2025.
A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed.
Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed,
Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal
(cut words struck through, new words highlighted).
Text on the page, not a score; each links to the filing at sec.gov.
What the 10-Q itself says about its risk factors:During the period covered by this report, there were no material changes from the risk factors previously disclosed in Ashland’s Annual Report on Form 10-K for the fiscal year ended September 30, 2025.
Read in the 10-Q
1 paragraph in the 10-Q's Item 1A, and none of them adds, rewords or quietly edits a paragraph of the 10-K's.
Phrases used for the first time
Two-word phrases in Risk Factors of the 10-K filed Nov 20, 2025 that are in none of the 1 earlier 10-Ks stored, back to Nov 18, 2024
Where each one is used
- reportable segments: Ashland has set aggressive growth goals for its reportable segments which may be impacted by such risks as the failure to optimize the use of Ashland’s tangible and intangible assets, the failure to identify and successfully integrate acquisition targets, and/or unexpected costs and liabilities associated with...
- ashland’s reportable: Business disruptions (including those related to operating hazards inherent with the production of chemicals) stemming from events such as natural disasters, severe weather conditions, supply or logistics disruptions, increasing costs for energy, temporary plant and/or power outages, information technology systems...
- risks inherent: Ashland’s substantial global operations subject it to risks inherent in doing business in foreign countries, including changes to tariffs and trade policy, geopolitical instability, and challenges in hiring and managing a diverse workforce across jurisdictions with differing labor and employment laws and cultural...
- geopolitical risks: Ashland’s global business operations present a range of challenges, particularly related to tariffs, trade policy, and geopolitical risks. The imposition of new tariffs or trade quotas, or the impairment of existing trade agreements, risks that have become more pronounced amid ongoing global trade tensions and...
- disrupt supply: financial performance. The uncertainty and volatility created by these policies, including heightened trade disputes, renegotiations of major agreements, and the risk of additional withholding taxes or restrictions on foreign trade and investment (such as currency exchange controls), may disrupt supply chains,...
- supply chains: financial performance. The uncertainty and volatility created by these policies, including heightened trade disputes, renegotiations of major agreements, and the risk of additional withholding taxes or restrictions on foreign trade and investment (such as currency exchange controls), may disrupt supply chains,...
- limit market: financial performance. The uncertainty and volatility created by these policies, including heightened trade disputes, renegotiations of major agreements, and the risk of additional withholding taxes or restrictions on foreign trade and investment (such as currency exchange controls), may disrupt supply chains,...
- market access: financial performance. The uncertainty and volatility created by these policies, including heightened trade disputes, renegotiations of major agreements, and the risk of additional withholding taxes or restrictions on foreign trade and investment (such as currency exchange controls), may disrupt supply chains,...
Used at least twice, small words left out. Counted, not picked: a phrase can be new because the company renamed something.
What was taken out
1 paragraph of last year's Risk Factors with nothing like them now. The longest are quoted.
Sources
Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.
Also
10-K change: what was reworded or cut, section by section.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ASH/export.csv") into a cell.